Concanavalin A promotes angiogenesis and proliferation in endothelial cells through the Akt/ERK/Cyclin D1 axis

References

• Arsenijevic D, Stojanovic B, Milovanovic J, Arsenijevic A, Simic M, Pergal M, Kodranov I, Cvetkovic O, Vojvodic D, Ristanovic E, et al. 2021. Hepatoprotective effect of mixture of dipropyl polysulfides in concanavalin A-induced hepatitis. Nutrients. 13(3):1022–1015.
   PubMed Web of Science ®Google Scholar
• Ballerstadt R, Evans C, McNichols R, Gowda A. 2006. Concanavalin A for in vivo glucose sensing: a biotoxicity review. Biosens Bioelectron. 22(2):275–284.
   PubMed Web of Science ®Google Scholar
• Baudin B, Bruneel A, Bosselut N, Vaubourdolle M. 2007. A protocol for isolation and culture of human umbilical vein endothelial cells. Nat Protoc. 2(3):481–485.
   PubMed Web of Science ®Google Scholar
• Biswas MH, Hasegawa HH, Rahman MA, Huang P, Mon NN, Ruhul Amin AR, Senga T, Kannagi R, Hamaguchi M. 2006. SHP-2-Erk signaling regulates concanavalin A-dependent production of TIMP-2. Biochem Biophys Res Commun. 348(3):1145–1149.
   PubMed Web of Science ®Google Scholar
• Blaes N, Girolami JP. 2013. Targeting the 'Janus face' of the B2-bradykinin receptor. Expert Opin Ther Targets. 17(10):1145–1166.
   PubMed Web of Science ®Google Scholar
• Che H, Li G, Sun HY, Xiao GS, Wang Y, Li GR. 2015. Roles of store-operated Ca2+ channels in regulating cell cycling and migration of human cardiac c-kit + progenitor cells. Am J Physiol Heart Circ Physiol. 309(10):H1772–H1781.
   PubMed Web of Science ®Google Scholar
• Chen CH, Jiang W, Via DP, Luo S, Li TR, Lee YT, Henry PD. 2000. Oxidized low-density lipoproteins inhibit endothelial cell proliferation by suppressing basic fibroblast growth factor expression. Circulation. 101(2):171–177.
   PubMed Web of Science ®Google Scholar
• Chen T, Karamariti E, Hong X, Deng J, Wu Y, Gu W, Simpson R, Wong MM, Yu B, Hu Y, et al. 2019. DKK3 (Dikkopf-3) Transdifferentiates fibroblasts into functional endothelial cells-brief report. Arterioscler Thromb Vasc Biol. 39(4):765–773.
   PubMed Web of Science ®Google Scholar
• Deanfield JE, Halcox JP, Rabelink TJ. 2007. Endothelial function and dysfunction: testing and clinical relevance. Circulation. 115(10):1285–1295.
   PubMed Web of Science ®Google Scholar
• Elshal M, Abu-Elsaad N, El-Karef A, Ibrahim T. 2021. Etanercept attenuates immune-mediated hepatitis induced by concanavalin A via differential regulation of the key effector cytokines of CD4+ T cells. Life Sci. 277:119618–119619.
   PubMed Web of Science ®Google Scholar
• Flammer AJ, Gossl M, Li J, Matsuo Y, Reriani M, Loeffler D, Simari RD, Lerman LO, Khosla S, Lerman A. 2012. Patients with an HbA1c in the prediabetic and diabetic range have higher numbers of circulating cells with osteogenic and endothelial progenitor cell markers. J Clin Endocrinol Metab. 97(12):4761–4768.
   PubMed Web of Science ®Google Scholar
• Fu C, Li B, Sun Y, Ma G, Yao Y. 2015. Bradykinin inhibits oxidative stress-induced senescence of endothelial progenitor cells through the B2R/AKT/RB and B2R/EGFR/RB signal pathways. Oncotarget. 6(28):24675–24689.
   PubMedGoogle Scholar
• Gantner F, Leist M, Lohse AW, Germann PG, Tiegs G. 1995. Concanavalin A-induced T-cell-mediated hepatic injury in mice: the role of tumor necrosis factor. Hepatology. 21(1):190–198.
   PubMed Web of Science ®Google Scholar
• Gong WG, Lin JL, Niu QX, Wang HM, Zhou YC, Chen SY, Liang GW. 2015. Paeoniflorin diminishes ConA-induced IL-8 production in primary human hepatic sinusoidal endothelial cells in the involvement of ERK1/2 and Akt phosphorylation. Int J Biochem Cell Biol. 62:93–100.
   PubMed Web of Science ®Google Scholar
• Ibrahim SRM, Sirwi A, Eid BG, Mohamed SGA, Mohamed GA. 2021. Summary of natural products ameliorate concanavalin A-induced liver injury: structures, sources, pharmacological effects, and mechanisms of action. Plants. 10(2):228–233.
   Google Scholar
• Kar F, Kacar S, Hacioglu C, Kanbak G, Sahinturk V. 2021. Concanavalin A induces apoptosis in a dose-dependent manner by modulating thiol/disulfide homeostasis in C6 glioblastoma cells. J Biochem Mol Toxicol. 35(5):e22742.
   PubMed Web of Science ®Google Scholar
• Khan HA, Munir T, Khan JA, Shafia Tehseen Gul AH, Ahmad MZ, Aslam MA, Umar MN, Arshad MI. 2021. IL-33 ameliorates liver injury and inflammation in Poly I:C and Concanavalin-A induced acute hepatitis. Microb Pathog. 150:104716.
   PubMed Web of Science ®Google Scholar
• Kulkarni GV, McCulloch CA. 1995. Concanavalin A induced apoptosis in fibroblasts: the role of cell surface carbohydrates in lectin mediated cytotoxicity. J Cell Physiol. 165(1):119–133.
   PubMed Web of Science ®Google Scholar
• Li CY, Xu HL, Liu B, Bao JK. 2010. Concanavalin A, from an old protein to novel candidate anti-neoplastic drug. Curr Mol Pharmacol. 3(3):123–128.
   PubMedGoogle Scholar
• Li G, Che H, Wu WY, Jie LJ, Xiao GS, Wang Y, Li GR. 2018. Bradykinin-mediated Ca2+ signalling regulates cell growth and mobility in human cardiac c-Kit+ progenitor cells. J Cell Mol Med. 22(10):4688–4699.
   PubMed Web of Science ®Google Scholar
• Li G, Kong D, Qin Y, Wang H, Hu Y, Zhao Y, Hao J, Qin H, Yu D, Zhu Y, et al. 2021. IL-37 overexpression enhances the therapeutic effect of endometrial regenerative cells in concanavalin A-induced hepatitis. Cytotherapy. 23(7):617–626.
   PubMed Web of Science ®Google Scholar
• Li G, Wang Y, Li GR. 2017. Bradykinin regulates cell growth and migration in cultured human cardiac c-Kit+ progenitor cells. Oncotarget. 8(7):10822–10835.
   PubMedGoogle Scholar
• Li WW, Yu JY, Xu HL, Bao JK. 2011. Concanavalin A: a potential anti-neoplastic agent targeting apoptosis, autophagy and anti-angiogenesis for cancer therapeutics. Biochem Biophys Res Commun. 414(2):282–286.
   PubMed Web of Science ®Google Scholar
• Li Y, Gong L, Weng L, Pan X, Liu C, Li M. 2021. Interleukin-39 exacerbates concanavalin A-induced liver injury. Immunopharmacol Immunotoxicol. 43(1):94–99.
   PubMed Web of Science ®Google Scholar
• Liu B, Bian HJ, Bao JK. 2010. Plant lectins: potential antineoplastic drugs from bench to clinic. Cancer Lett. 287(1):1–12.
   PubMed Web of Science ®Google Scholar
• Liu B, Li CY, Bian HJ, Min MW, Chen LF, Bao JK. 2009. Antiproliferative activity and apoptosis-inducing mechanism of Concanavalin A on human melanoma A375 cells. Arch Biochem Biophys. 482(1–2):1–6.
   PubMed Web of Science ®Google Scholar
• Luo ML, Liu XP, Wang F, Liu XX, Liu WF, Wu D, Tao H, Wang RL, Zhao Y, Zhu JW, et al. 2018. Conditioned medium from human umbilical vein endothelial cells promotes proliferation, migration, invasion and angiogenesis of adipose derived stem cells. Curr Med Sci. 38(1):124–130.
   PubMed Web of Science ®Google Scholar
• McMillan PN, Ferayorni LS, Gerhardt CO, Jauregui HO. 1984. Light and electron microscope analysis of lectin binding to adult rat liver in situ. Lab Invest. 50(4):408–420.
   PubMed Web of Science ®Google Scholar
• Meng Z, Wang J, Yuan Y, Cao G, Fan S, Gao C, Wang L, Li Z, Wu X, Wu Z, et al. 2017. γδ T cells are indispensable for interleukin-23-mediated protection against concanavalin A-induced hepatitis in hepatitis B virus transgenic mice. Immunology. 151(1):43–55.
   PubMed Web of Science ®Google Scholar
• Miethke T, Wahl C, Heeg K, Echtenacher B, Krammer PH, Wagner H. 1992. T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of tumor necrosis factor. J Exp Med. 175(1):91–98.
   PubMed Web of Science ®Google Scholar
• Nicoletti NF, Erig TC, Zanin RF, Pereira TC, Bogo MR, Campos MM, Morrone FB. 2014. Mechanisms involved in kinin-induced glioma cells proliferation: the role of ERK1/2 and PI3K/Akt pathways. J Neurooncol. 120(2):235–244.
   PubMed Web of Science ®Google Scholar
• Peschke T, Wollweber L, Gabert A, Augsten K, Stracke R. 1990. Effect of different fixatives on Con A surface receptors of mouse peritoneal macrophages. Histochemistry. 93(4):443–446.
   PubMedGoogle Scholar
• Pink JR, Hoessli D, Tartakoff A, Hooghe R. 1983. Characterisation of concanavalin A-binding glycoproteins from mouse splenic leukocytes by two-dimensional electrophoresis: preferential binding of incompletely glycosylated forms of H-2 antigen to the lectin. Mol Immunol. 20(4):491–497.
   PubMed Web of Science ®Google Scholar
• Pober JS, Min W, Bradley JR. 2009. Mechanisms of endothelial dysfunction, injury, and death. Annu Rev Pathol. 4:71–95.
   PubMed Web of Science ®Google Scholar
• Ruhul Amin AR, Oo ML, Senga T, Suzuki N, Feng GS, Hamaguchi M. 2003. SH2 domain containing protein tyrosine phosphatase 2 regulates concanavalin A-dependent secretion and activation of matrix metalloproteinase 2 via the extracellular signal-regulated kinase and p38 pathways. Cancer Res. 63(19):6334–6339.
   PubMed Web of Science ®Google Scholar
• Sang XX, Wang RL, Zhang CE, Liu SJ, Shen HH, Guo YM, Zhang YM, Niu M, Wang JB, Bai ZF, et al. 2017. Sophocarpine protects mice from con A-induced hepatitis via inhibition of the IFN-Gamma/STAT1 Pathway. Front Pharmacol. 8:1–9.
   PubMed Web of Science ®Google Scholar
• Sasaki N, Toyoda M. 2013. Glycoconjugates and related molecules in human vascular endothelial cells. Int J Vasc Med. 2013:963596–963510.
   PubMedGoogle Scholar
• Schaumburg-Lever G. 1990. Ultrastructural localization of lectin-binding sites in normal skin. J Invest Dermatol. 94(4):465–470.
   PubMed Web of Science ®Google Scholar
• Schober A, Nazari-Jahantigh M, Wei Y, Bidzhekov K, Gremse F, Grommes J, Megens RT, Heyll K, Noels H, Hristov M, et al. 2014. MicroRNA-126-5p promotes endothelial proliferation and limits atherosclerosis by suppressing Dlk1. Nat Med. 20(4):368–376.
   PubMed Web of Science ®Google Scholar
• Sina A, Proulx-Bonneau S, Roy A, Poliquin L, Cao J, Annabi B. 2010. The lectin concanavalin-A signals MT1-MMP catalytic independent induction of COX-2 through an IKKgamma/NF-kappaB-dependent pathway. J Cell Commun Signal. 4(1):31–38.
   PubMed Web of Science ®Google Scholar
• Singh N, Singh H, Jagavelu K, Wahajuddin M, Hanif K. 2017. Fatty acid synthase modulates proliferation, metabolic functions and angiogenesis in hypoxic pulmonary artery endothelial cells. Eur J Pharmacol. 815:462–469.
   PubMed Web of Science ®Google Scholar
• Tong Q, Zheng L, Li B, Wang D, Huang C, Matuschak GM, Li D. 2006. Hypoxia-induced mitogenic factor enhances angiogenesis by promoting proliferation and migration of endothelial cells. Exp Cell Res. 312(18):3559–3569.
   PubMed Web of Science ®Google Scholar
• Velasquez EV, Rios M, Ortiz ME, Lizama C, Nunez E, Abramovich D, Orge F, Oliva B, Orellana R, Villalon M, et al. 2013. Concanavalin-A induces granulosa cell death and inhibits FSH-mediated follicular growth and ovarian maturation in female rats. Endocrinology. 154(5):1885–1896.
   PubMed Web of Science ®Google Scholar
• Yu P, Zhang Z, Li S, Wen X, Quan W, Tian Q, Chen J, Zhang J, Jiang R. 2016. Progesterone modulates endothelial progenitor cell (EPC) viability through the CXCL12/CXCR4/PI3K/Akt signalling pathway. Cell Prolif. 49(1):48–57.
   PubMed Web of Science ®Google Scholar
• Zhang M, Li Q, Zhou C, Zhao Y, Li R, Zhang Y. 2020. Demethyleneberberine attenuates concanavalin A-induced autoimmune hepatitis in mice through inhibition of NF-κB and MAPK signaling. Int Immunopharmacol. 80:106137.
   PubMed Web of Science ®Google Scholar
• Zhang YY, Li G, Che H, Sun HY, Xiao GS, Wang Y, Li GR. 2015. Effects of BKCa and Kir2.1 channels on cell cycling progression and migration in human cardiac c-kit+ progenitor cells. PLOS One. 10(9):e0138581.
   PubMed Web of Science ®Google Scholar